CapsoVision (CV) Asset Utilization Ratio (2025 - 2026)
CapsoVision (CV) posted Asset Utilization Ratio of 0.65 for Q4 2025, down 13.9% sequentially from 0.75 in Q3 2025.
CapsoVision (CV) Asset Utilization Ratio (2025 - 2026) Analysis & Trends
CapsoVision has reported Asset Utilization Ratio for 1 years, with the latest figure at 0.65 in Q4 2025.
- Quarterly Asset Utilization Ratio changed N/A year-over-year to 0.65 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 0.65 (changed N/A YoY) and the FY2025 annual result came in at 0.78, changed N/A from the prior year.
- Asset Utilization Ratio fell to 0.65 in Q4 2025 per CV's latest filing, from 0.75 in the prior quarter.
- Over five years, Asset Utilization Ratio peaked at 0.95 in Q2 2025 and troughed at 0.65 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 0.42 |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 0.55 |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 0.39 |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 0.47 |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 0.48 |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 0.76 |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 0.57 |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 0.80 |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 0.56 |
| 10 | CapsoVision | 295.13 Mn | 286.05 Mn | 1.87 Mn | 0.78 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.78 |
| Dec 31, 2025 | 0.65 |
| Sep 30, 2025 | 0.75 |
| Jun 30, 2025 | 0.95 |